Cargando…
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell transplantation seems to be promising in recent...
Autores principales: | Pandit, Awadh Kishor, Prasad, Kameshwar, Seth, Tulika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683892/ https://www.ncbi.nlm.nih.gov/pubmed/26713025 http://dx.doi.org/10.4103/0972-2327.165482 |
Ejemplares similares
-
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017) -
Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018) -
The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation
por: Servaas, N. H., et al.
Publicado: (2020) -
Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020) -
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)